Status:
COMPLETED
PrEP2Prevent An Online PrEP Navigation and Activation Intervention
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
Florida State University
Conditions:
HIV Infections
Eligibility:
All Genders
16-26 years
Phase:
NA
Brief Summary
* The goal of this clinical trial entitled, PrEP2Prevent: An Online PrEP Navigation and Activation Intervention for YMSM, is to develop and test a method for supporting access to an HIV prevention med...
Detailed Description
The U.S. Department of Health and Human Services (HHS) has set a goal to end the HIV epidemic by the year 2030, which is well within reach given the availability of antiretrovirals that effectively pr...
Eligibility Criteria
Inclusion
- Phase 1A:
- Inclusion criteria:
- PrEP providers serving YMSM from healthcare and community-based organizations located in Los Angeles County or PrEP Navigators similarly employed by healthcare and community-based organizations that deliver PrEP services to YMSM.
- \>18 years of age
- Exclusion criteria:
- Not a PrEP provider or navigator serving YMSM from healthcare and community-based organizations located in Los Angeles County
- under 18 years of age
- Phase 1B and Phase 2:
- Inclusion criteria:
- 16-26 years old
- cisgender male, Trans, gender non-conforming, or identify differently from the gender picked for you at birth
- identify as gay, bisexual, or some other same-sex identity, and/or report having had sex with anyone with a penis during the previous 12 months
- identify as White/Caucasian, Black/African American, Latinx, Asian-Pacific Islander, Indigenous, Native American or mixed-race
- living in the Los Angeles metro area
- have daily access to an iOS/Android smartphone and/or tablet with internet access
- know their HIV status and are HIV negative at time of enrollment.
- Exclusion Criteria:
- is younger than or older than 16- to 26-years
- not cisgender male, Trans, gender non-conforming, or identify differently from the gender picked for you at birth
- does not identify as gay, bisexual, or some other same-sex identity, and/or report having had sex with anyone with a penis during the previous 12 months
- does not identify as White/Caucasian, Black/African American, Latinx, Asian-Pacific Islander, Indigenous, Native American or mixed-race
- does not report living in the Los Angeles metro area
- is non-English speaking
- does not have daily access to an iOS/Android smartphone and/or tablet with internet access
- is a person living with HIV
- for Phase 2 only, participants will be excluded if they participated in the Phase 1B focus groups
- Phase 3:
- Inclusion criteria:
- 16-26 years old
- cisgender male, Trans, gender non-conforming, or identify differently from the gender picked for you at birth
- identify as gay, bisexual, or some other same-sex identity, and/or report having had sex with anyone with a penis during the previous 12 months
- identify as White/Caucasian, Black/African American, Hispanic/Latino/Latinx, or mixed-race
- living in the Los Angeles metro area
- have daily access to an iOS/Android smartphone and/or tablet with internet access
- report having insertive and/or receptive anal sex in the previous 6 months or report a positive STI result in the previous 6 months
- not currently on PrEP and no plan to start/restart PrEP in the following 7 days
- not currently enrolled in another HIV prevention study
- Exclusion criteria:
- is younger than or older than 16- to 26-years
- not cisgender male, Trans, gender non-conforming, or identify differently from the gender picked for you at birth
- does not identify as gay, bisexual, or some other same-sex identity, and/or does not report having had sex with anyone with a penis during the previous 12 months
- does not identify as White/Caucasian, Black/African American, Hispanic/Latino/Latinx, or mixed-race
- does not report living in the Los Angeles metro area
- is non-English speaking
- is a person living with HIV (self-reported)
- does not report insertive and/or receptive anal sex in the previous 6 months or does not report a positive STI result in the previous 6 months
- does not have daily access to an iOS/Android smartphone and/or tablet with internet access
- is currently on PrEP or has plans to start/restart PrEP in the following 7 days; and 11) is currently enrolled in another HIV prevention study.
Exclusion
Key Trial Info
Start Date :
January 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05281393
Start Date
January 28 2021
End Date
January 3 2024
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027